https://www.facebook.com/593798673816496/

Connecticut CannaTimes, Hartford, CT (2026)

06/12/2026

SEC Discusses “Enforcement Opportunities” : Why That Language Should Concern Connecticut’s Cannabis Community

By CT CannaTimes - 6.12.2026

A phrase buried within a June 2, 2026 Social Equity Council legislative update may raise uncomfortable questions for patients, advocates, and cannabis entrepreneurs across Connecticut.

While presenting an overview of legislation affecting Connecticut’s cannabis industry, Social Equity Council Chief Legal Officer Nichelle Mullins described the purpose of the state’s Cannabis, H**p, and Controlled Substances Enforcement Board.

According to Mullins, the board’s primary function is to examine:

“enforcement opportunities, scientific developments, and industry trends related to cannabis, h**p, and related products.”

For many observers, one phrase stands out.

Enforcement opportunities.

The wording may appear minor. But in the context of Connecticut’s cannabis legalization framework—and particularly within an agency created to address harms caused by cannabis prohibition—it deserves closer examination.

What Exactly Is An “Enforcement Opportunity”?

Government agencies commonly discuss:

* regulatory compliance;
* consumer protection;
* public health safeguards;
* enforcement priorities;
* enforcement challenges; or
* enforcement activities.

But “enforcement opportunities” carries a distinctly different meaning.

An opportunity is generally understood as something desirable to pursue.

When regulators discuss “business opportunities,” everyone understands the goal is to create more business activity.

When agencies discuss “economic opportunities,” the objective is expanding economic growth.

So what exactly is meant by an “enforcement opportunity”?

More inspections?

More investigations?

More penalties?

More license actions?

More enforcement operations?

The phrase naturally raises those questions.

Why This Matters

The Social Equity Council was not created to expand cannabis enforcement.

It was created because of the consequences of cannabis enforcement.

Connecticut’s legalization law was built around the recognition that decades of cannabis prohibition disproportionately harmed certain communities through arrests, criminal records, barriers to employment, and lost economic opportunity.

The Council’s statutory mission centers on social equity, community reinvestment, entrepreneurship, and repairing those harms.

That history makes the phrase “enforcement opportunities” particularly jarring.

Many patients and advocates spent years fighting against excessive cannabis enforcement.

To hear a state cannabis official describe a board’s mission using language focused on identifying enforcement opportunities can sound less like reform and more like a continuation of the enforcement mindset legalization was supposed to move beyond.

A Matter of Messaging—or Policy?

To be clear, it is possible that Mullins was simply summarizing statutory language or speaking informally during her presentation.

The phrase may have been intended to refer to:

* illicit market enforcement;
* public safety concerns;
* unlicensed operators;
* h**p compliance issues; or
* consumer protection initiatives.

However, the language still matters.

Words chosen by regulators reveal how agencies think about their mission.

The difference between:

“identifying regulatory challenges”

and

“identifying enforcement opportunities”

is not merely semantic.

One focuses on solving problems.

The other focuses on finding opportunities to enforce.

Questions Worth Asking

Connecticut cannabis patients, entrepreneurs, and advocates deserve clarity.

What specific enforcement opportunities is the board evaluating?

Are these opportunities focused on:

* unlicensed cannabis sales?
* h**p businesses?
* licensed operators?
* consumers?
* municipalities?
* public health concerns?

And perhaps most importantly:

How does a state board tasked with helping shape the future of Connecticut cannabis define success?

Through greater opportunity for entrepreneurs and patients?

Or through greater opportunity for enforcement?

The answer matters.

Because Connecticut’s cannabis system was sold to the public as a departure from the failures of prohibition—not as a new search for enforcement opportunities.

For an agency built upon the principles of social equity, the language used to describe its mission should reflect that reality.

06/12/2026

“Attorney Mullins Works for the Council”: Liability Discussion Sparks Rare Governance Clash at Connecticut Social Equity Council Meeting

By CT CannaTimes Staff - 6.12.2026

A routine Connecticut Social Equity Council meeting took an unexpected turn on May 5 when a discussion about liability protections, legal disclaimers, and loan programs evolved into a public disagreement over the relationship between Council members and agency staff.

The exchange occurred during a broader update from Executive Director Brandon McGee regarding agency operations, staffing, finances, community reinvestment programs, and legislative activities.

The discussion began when Council member Avery Gaddis raised a series of questions about the Social Equity Council’s potential liability exposure.

Gaddis first asked whether the Council provides legal advice to members of the public. McGee responded that it does not. Staff attorney Attorney Collazo Cruz explained that legal staff provide guidance regarding whether applications and supporting documentation satisfy statutory requirements but that stakeholders are advised to seek legal advice from their own counsel.

Gaddis then turned her attention to liability protections.

According to the meeting minutes, she asked what safeguards exist to protect the Social Equity Council if an applicant is denied a loan, whether staff communications contain legal disclaimers, and whether applicants are required to sign waivers.

The responses appeared to raise concerns.

Council staff confirmed that the agency does not currently have legal disclaimers on its emails or website.

The issue is notable because the Social Equity Council administers social equity verification programs, entrepreneur assistance initiatives, grants, loans, technical assistance programs, and other services that frequently involve communication with prospective applicants and business owners.

At that point, newly hired Chief Legal Officer Attorney Nichelle Mullins suggested that the discussion be moved to a committee setting where the issues could be more fully explored and potential solutions identified.

Gaddis immediately pushed back.

According to the official meeting minutes:

“Council member Gaddis addressed Chair Comer indicating that she does not want staff members suggesting to table anything.”

The exchange escalated further.

The minutes continue:

“She then addressed Attorney Mullins stating that she does not work for her; Attorney Mullins works for her. If she or the Council want to talk about an issue, they will talk about it.”

The statement represented one of the strongest assertions of Council authority recorded in recent Social Equity Council meeting minutes.

While there was no indication of personal animosity, the exchange highlighted an important governance question: who ultimately controls the Council’s discussions and priorities—the appointed governing body or the professional staff who support it?

Mullins serves as Chief Legal Officer and is part of the agency’s staff structure. Gaddis serves as a voting member of the governing Council itself.

The disagreement appeared less about disclaimers and more about authority.

Council Chair Andréa Comer moved quickly to de-escalate the situation.

According to the minutes, Comer acknowledged Gaddis’ concerns while explaining that Mullins’ recommendation was intended to move the discussion into a setting better suited for developing solutions. Comer also expressed support for continuing the discussion and referenced the possibility of implementing disclaimer mechanisms through electronic acknowledgement systems.

Other Council members soon joined the conversation.

Council member Shirley Skyers-Thomas suggested moving the discussion to a committee meeting or executive session. Council member Ojala Naeem commented on the need for additional clarity regarding programming. Council member Andréa Hawkins emphasized the importance of providing Council members with sufficient information to answer stakeholder questions. Council member Michael Jefferson suggested adding disclaimers to emails and the agency website while also commending McGee and staff for their work.

No formal action was taken.

Instead, staff agreed to provide additional information and continue discussions regarding liability protections, communication practices, and program administration.

The exchange stood out because it occurred during an otherwise routine meeting dominated by unanimous votes and administrative updates.

Earlier in the meeting, the Council unanimously approved multiple Equity Joint Venture applications and received updates regarding staffing expansion, grant programs, strategic planning, and agency finances. McGee reported that the Council’s Fiscal Year 2026 budget remains approximately $17 million, with April expenditures totaling roughly $238,000.

Yet it was the liability discussion—and the ensuing disagreement over governance authority—that emerged as the most revealing moment of the meeting.

For observers of Connecticut’s cannabis industry, the exchange offered a rare public glimpse into how the Social Equity Council is navigating the challenges that come with managing millions of dollars in programs, expanding staff, growing public responsibilities, and defining the boundaries between elected governance and professional administration.

As the Council continues expanding its role in Connecticut’s cannabis market, questions surrounding liability, transparency, public communications, and institutional accountability are likely to remain at the forefront.

And on May 5, those questions briefly produced one of the most candid exchanges seen inside the Council chambers in recent memory.

06/10/2026

Read The Article, Think For Yourself

06/10/2026

Would Fentanyl Even Survive a Burning Joint?
The Chemistry Problem Behind the “Fentanyl-Laced Weed” Panic

By CT CannaTimes Editor - 6.10.2026

The phrase “fentanyl-laced cannabis” is frightening because fentanyl is frightening. Nobody serious should minimize fentanyl. It is potent, dangerous, and responsible for mass overdose deaths across the country.

But fear is not chemistry.

And the chemistry raises a basic question that rarely gets asked in police press releases or headlines:

Would fentanyl even survive being smoked in a joint, blunt, or bowl?

The answer is not a clean yes or no. But the temperatures involved create a major plausibility problem for the idea that cannabis flower is being widely or intentionally used as a fentanyl delivery system.

Fentanyl does not have one magic “inactive at this exact temperature” number. It depends on the form of fentanyl, the exposure time, oxygen, moisture, and what else is burning with it.

But available federal response guidance lists fentanyl free base as melting around 181–183°F.

Fentanyl citrate, a common pharmaceutical salt form, melts around 307–313°F.

Synthetic opioids generally begin significant thermal decomposition at elevated temperatures, often discussed around 572°F and above. Fentanyl free base has also been described as charring around 736°F.

That matters because a burning cannabis joint is much hotter than that.

A butane lighter flame is commonly around 1,500–1,800°F in normal use, with the hottest regions potentially much higher.

The burning tip of a cigarette-like joint or blunt can reach roughly 750–1,100°F while smoldering and around 1,200–1,650°F during an active puff. Some of the hottest ember regions can exceed 1,800°F.

So the obvious first point is this:

The burning end of a joint is hot enough to damage, decompose, char, or destroy fentanyl.

If fentanyl begins degrading around 572°F, chars around 736°F, and the joint ember during a puff may be 1,200–1,650°F, then the “laced w**d” story immediately runs into a chemistry problem.

A person is not gently warming fentanyl. They are pulling air through a tiny burning plant furnace.

That does not mean fentanyl exposure from contaminated cannabis is impossible. A joint is not a perfect laboratory incinerator. It does not heat every particle evenly. There is a very hot combustion zone at the cherry, a cooler zone behind it, unburned plant material, resin, ash, smoke particles, and fast-moving airflow.

Some material burns. Some vaporizes. Some partially decomposes. Some may ride along in smoke or aerosol particles before being fully destroyed.

That is why the honest scientific answer is not “impossible.”

The honest answer is:

Smoking cannabis is a very inefficient, unpredictable, and chemically hostile way to deliver fentanyl.

That distinction matters.

If fentanyl powder were sprinkled directly onto flower and then hit with a lighter flame around 1,500°F or hotter, some of it would likely be destroyed immediately. If it sat in the ember during a puff at 1,200–1,650°F, more would likely break down. If some particles were pulled through cooler areas before full combustion, some fraction might survive or transform into other compounds.

But that is not a reliable dosing method. It is not predictable. It is not efficient. It is not commercially logical.

This is the part most public warnings skip.

If someone wanted to sell fentanyl, cannabis flower would be one of the dumbest delivery methods available. Fentanyl is potent in tiny amounts. It is already commonly found in he**in, counterfeit pills, co***ne, and other powder-based drug markets where it can be mixed more evenly and consumed without being blasted through a 1,200–1,650°F ember.

Putting fentanyl on cannabis flower means risking heat destruction, uneven dosing, customer death, police attention, and product waste.

That does not sound like a rational business model. It sounds more like panic, rumor, or isolated contamination.

Cross-contamination is more plausible than intentional lacing. If cannabis and fentanyl were handled on the same surface, scale, bagging area, grinder, or packaging equipment, a small amount of fentanyl could contaminate flower. That would not require a coordinated plan to create “fentanyl w**d.” It would require sloppy illegal-market handling.

Connecticut has already lived through this panic.

In 2021, officials warned about suspected ma*****na-related overdose cases. The public heard “fentanyl-laced ma*****na.” But later review found that many of the reported incidents involved opioid history, multiple substances, or other major confounding factors. Connecticut eventually identified one confirmed cannabis sample containing fentanyl, and that case was later assessed as likely isolated and unintentional contamination.

That is a very different story from “fentanyl-laced w**d is everywhere.”

The temperature evidence should force better questions.

If fentanyl starts breaking down around 572°F, chars around 736°F, and a joint can burn at 1,200–1,650°F during a puff, then reporters, police, and regulators should stop treating cannabis flower as an obvious fentanyl delivery vehicle.

They should ask:

How was the sample tested?

Was fentanyl found in the flower itself, the packaging, the residue, or a user’s toxicology report?

Were other drugs present?

Was the cannabis from a regulated dispensary, the illicit market, or an unknown source?

Was there evidence of intentional lacing, or only contamination?

Was the fentanyl evenly distributed through the cannabis, or found as trace residue?

Did anyone test whether a meaningful dose would survive actual smoking conditions?

Those are the questions that separate public health from drug-war folklore.

None of this means fentanyl is safe. None of this means contamination cannot happen. None of this means people should ignore overdose risk. Naloxone should be widely available. Drug checking should be expanded. People should be warned about contaminated illicit supplies.

But the claim “fentanyl-laced cannabis” should require actual proof.

Because the physics matter.

The chemistry matters.

And a burning joint is not a passive delivery device. It is a combustion system hot enough to reach temperatures far above the point where fentanyl begins degrading.

The more precise conclusion is this:

Fentanyl-contaminated cannabis is possible. Widespread intentional fentanyl-laced cannabis flower is far less plausible. And smoking cannabis is likely a chemically inefficient way to deliver fentanyl because the burning tip of a joint can reach temperatures hundreds of degrees hotter than fentanyl’s known degradation range.

That is not denial.

That is basic science.

06/10/2026

Bridgeport Police Say Cannabis Products Tested Positive for Fentanyl. The Charges Raise Questions.

CT CannaTimes Editor - 6.11.2026

Bridgeport Police announced this week that cannabis and THC products seized from Dice Convenience Smoke Shop at 4016 Main Street “tested positive for the presence of fentanyl.”

The statement was alarming.

It was also familiar.

Connecticut has been here before.

In 2021, state officials issued highly publicized warnings regarding alleged fentanyl-laced cannabis after a series of overdose investigations. National headlines followed. Public concern exploded. Subsequent reporting found that many of the suspected cases lacked evidence proving fentanyl-contaminated ma*****na, and state officials ultimately acknowledged that laboratory confirmation existed for only a very limited number of cases.

NBC Connecticut later reported that experts believed at least one confirmed Connecticut case was likely accidental contamination rather than evidence of a widespread intentional adulteration scheme. Connecticut’s original fentanyl-ma*****na narrative proved significantly narrower than many residents were initially led to believe.

That history does not prove Bridgeport Police are wrong today.

But it does mean extraordinary claims deserve extraordinary evidence.

And so far, the public has not seen that evidence.

What Police Claimed

According to the Bridgeport Police Department, officers executed a search warrant at Dice Convenience Smoke Shop on May 29, 2026.

Police reported seizing approximately 23.24 pounds of cannabis and THC products along with $654 in cash allegedly connected to illegal cannabis sales.

The department further stated:

“The prepackaged cannabis products seized from Dice Convenience Smoke Shop later tested positive for the presence of fentanyl.”

That statement immediately became the centerpiece of news coverage.

Yet no laboratory report, chain-of-custody record, concentration data, confirmation testing methodology, or product-specific analysis has been publicly released.

The public has been asked to accept the conclusion without being shown the evidence.

What the Court Docket Actually Shows

The Judicial Branch docket paints a more nuanced picture.

The defendant was charged with:

* CGS §21a-277(c): Conspiracy to Commit Operation of a Drug Factory

* CGS §21a-277(a): Conspiracy to Commit Sale of a Narcotic Substance

* CGS §21a-279(a)(1): Possession of a Controlled Substance

* CGS §21a-279a(b)(1)(A): Possession of Cannabis

* CGS §21a-278(b)(1)(D): Conspiracy to Commit Possession with Intent to Distribute More Than One Kilogram of Cannabis

Notably, the charging package appears heavily focused on cannabis distribution allegations.

One charge specifically references possession with intent to distribute more than one kilogram of cannabis.

Another specifically references cannabis possession.

Only one charge explicitly references a narcotic substance.

What These Statutes Actually Mean

CGS §21a-279 is Connecticut’s general possession statute for controlled substances other than cannabis.

It is broad.

A charge under §21a-279 could involve fentanyl, he**in, co***ne, prescription medications, or numerous other controlled substances. By itself, the statute does not tell the public which substance was allegedly possessed.

CGS §21a-277(a) covers the illegal manufacture, distribution, sale, prescription, dispensing, transportation, or possession with intent to sell a narcotic or hallucinogenic substance.

Fentanyl qualifies as a narcotic substance under Connecticut’s controlled substance framework.

Therefore, this charge is certainly consistent with a fentanyl allegation.

However, it is equally important to understand what the charge does not establish.

The charge does not identify fentanyl by name.

The charge does not identify quantity.

The charge does not establish that fentanyl was found inside cannabis.

The charge does not establish that fentanyl-contaminated cannabis was being sold.

The charge simply establishes that prosecutors are alleging some form of narcotic-substance offense.

CGS §21a-278(b)(1)(D), meanwhile, specifically addresses possession with intent to distribute more than one kilogram of cannabis.

That is an explicitly cannabis-focused trafficking allegation.

What Is Missing?

This is where the case becomes interesting.

If the central public-health concern is fentanyl-contaminated cannabis, several obvious questions remain unanswered:

* What laboratory performed the testing?
* Was confirmatory testing performed?
* Which specific product tested positive?
* Was fentanyl detected in cannabis flower?
* Was fentanyl detected in gummies?
* Was fentanyl detected in v**e products?
* Was fentanyl detected on packaging?
* Was fentanyl detected elsewhere in the store?
* What concentration was detected?
* Was independent verification performed?

None of those details have been publicly released.

Why Connecticut Consumers Should Be Careful Before Jumping to Conclusions

The history here matters.

Connecticut’s 2021 fentanyl-cannabis scare demonstrates how quickly an alarming narrative can spread before all the facts become available.

Public skepticism is not denial.

It is a recognition that claims involving fentanyl contamination deserve a higher evidentiary standard than a press release.

Fentanyl contamination is possible.

A narcotics charge appears on the docket.

Nothing in the available record proves Bridgeport Police fabricated the allegation.

But nothing currently released to the public proves that cannabis flower sold at the store was intentionally laced with fentanyl either.

Those are two very different claims.

One is supported by the existence of a narcotics-related charge.

The other would require laboratory evidence that has not yet been released.

The Question That Remains

The most important question is not whether fentanyl contamination is theoretically possible.

It is whether authorities can produce the laboratory documentation necessary to support one of the most alarming claims that can be made about a cannabis product.

Until that evidence is released, Connecticut consumers should remember the lesson from 2021:

Headlines come first.

Evidence often comes later.

And sometimes the final story looks very different from the first one.

06/10/2026

Cannabis Equity Grants Need Public Trust. So Why Is Doug McCrory Hosting the Forum on June 11th, 2026 ?

By CT CannaTimes Editor - 6.10.2026

As Connecticut prepares to distribute millions of dollars in cannabis tax revenue through the Social Equity Council’s Reimagine & Revitalize (R2) Community Reinvestment Program, an uncomfortable question is emerging:

Why is State Senator Doug McCrory serving as a public-facing host for an informational forum promoting the program while remaining under an active federal investigation involving allegations of state grant steering?

The question is not whether McCrory has been charged with a crime. He has not.

The question is not whether misconduct has occurred within the R2 program. No evidence currently establishes that.

The question is whether Connecticut’s cannabis-equity system can afford even the appearance of recreating the same grant-distribution dynamics that are already under federal scrutiny.

A $36 Million Cannabis Grant Program

The Social Equity Council’s R2 Community Reinvestment Program is one of the largest cannabis-funded community investment initiatives in Connecticut history.

The program is expected to distribute approximately $36 million over three years, directing cannabis tax revenue into Community-Based Organizations operating within the state’s designated Disproportionately Impacted Areas (DIAs). According to program materials, funding decisions ultimately flow through regional grant managers and require approval through the Social Equity Council structure. Applications for the current cycle remain open through July 15.

On June 11, Sen. Doug McCrory and Rep. Joshua Hall are scheduled to participate in a public informational forum alongside the Social Equity Council to discuss the program and encourage participation.

Ordinarily, such events would attract little controversy.

But these circumstances are anything but ordinary.

The Shadow of Blue Hills

McCrory remains the subject of a federal investigation tied to the now-collapsed Blue Hills Civic Association, a Hartford nonprofit that received millions in state funding.

According to reporting cited in investigative records and public audits, federal grand jury subpoenas sought records involving approximately a dozen Hartford-area organizations as well as communications regarding McCrory’s relationships with certain grant recipients and associates. McCrory has not been charged and has repeatedly denied wrongdoing.

A state forensic audit released earlier this year painted a troubling picture.

The audit found that more than $11 million flowed through Blue Hills between 2023 and 2025, while only a fraction remained with the organization itself. Auditors concluded that records and communications suggested McCrory exercised significant influence over how funds were distributed and cited conduct that they said “strongly suggest[s] potential fraud and misappropriation of public funds.” McCrory has disputed those findings and characterized the audit as inaccurate and biased.

Perhaps most concerning were documents reportedly describing Blue Hills as a “conduit” through which additional funding could be directed to other organizations. Internal records reportedly included funding lists labeled “PER CONVERSATIONS WITH SENATOR MCCRORY.”

Those allegations remain unproven in court.

But they are exactly why the optics surrounding the June 11 event matter.

Why Cannabis Advocates Should Care

The Social Equity Council was created to ensure cannabis legalization delivered tangible benefits to communities disproportionately harmed by prohibition.

Trust is essential to that mission.

Patients, consumers, applicants, taxpayers, and community organizations must believe that funding decisions are being made through transparent, objective processes rather than political relationships.

That trust has already been strained.

In 2024, Connecticut Comptroller Sean Scanlon issued a special examination of the Social Equity Council that found no direct evidence of criminal wrongdoing but identified what he described as questionable business practices, subjective decision-making, and insufficient safeguards. The report recommended reforms and contributed to a pause in funding activity before the launch of the redesigned R2 framework.

Against that backdrop, placing a lawmaker currently under investigation for alleged grant-steering at the center of a public event promoting cannabis-funded grants creates an unavoidable appearance problem.

Whether fair or unfair, the image projected to the public is difficult to ignore.

The McGee Connection

The situation becomes even more complicated because the event is being conducted alongside the Social Equity Council led by CEO Brandon McGee.

McGee is not a subject of the federal investigation and has stated publicly that he was unaware that a $20,000 contribution linked to a Blue Hills-funded event originated from state grant money. There is no evidence that McGee engaged in wrongdoing.

Nevertheless, records cited in the investigative analysis show that McCrory and McGee previously co-hosted the “When Black Men Lead” event that received the contribution.

Again, that does not establish misconduct.

But when public confidence is already fragile, perceptions matter.

The Real Issue

The central concern is not that Sen. McCrory is guilty of anything.

The central concern is that Connecticut’s cannabis-equity infrastructure should be operating above suspicion.

The state’s own audit findings, ongoing federal scrutiny, and previous controversies surrounding grant administration have created an environment where appearances carry enormous weight.

If the Social Equity Council wants the public to trust the R2 program, it should make crystal clear that legislators play no role in evaluating applications, scoring proposals, selecting recipients, or influencing funding outcomes.

The public should never be left wondering whether attending a legislator-hosted forum could somehow improve an organization’s chances of receiving cannabis-funded grants.

That uncertainty alone is damaging.

Questions That Deserve Answers

Before applications close, the Social Equity Council should publicly address several straightforward questions:

* What specific safeguards prevent legislative influence over R2 funding decisions?

* Are any organizations connected to individuals named in the Blue Hills investigation eligible to receive R2 funding?

* How are conflicts of interest screened and disclosed?

* Why was it deemed appropriate to feature a legislator currently under federal investigation in a public-facing role promoting the program?

Connecticut’s cannabis industry has spent years promising transparency, accountability, and community reinvestment.

The R2 program may ultimately achieve those goals.

But public trust is difficult to build and easy to lose.

At a moment when Connecticut is attempting to prove that cannabis tax revenue can be distributed fairly and ethically, appearances matter almost as much as outcomes.

And right now, the appearance is raising questions that deserve answers.

Connecticut CannaTimes

06/12/2026

06/12/2026

06/10/2026

06/10/2026

06/10/2026

06/10/2026

Address

Website

Alerts

Shortcuts

Share

Category